BioMistral: Open-Source Pretrained LLMs for the Medical Domain
> Source: https://arxiv.org/abs/2402.10373 (February 2024) > Authors: Yanis Labrak, Adrien Bazoge, Emmanuel Morin, Pierre-Antoine Gourraud, Mickael Rouvier, Richard Dufour
Overview
BioMistral is a suite of fully open-source large language models tailored to the biomedical domain. It is built by continued pretraining of Mistral 7B on the complete English PubMed Central corpus, producing the base model BioMistral 7B.
Key contributions
- BioMistral 7B: continued pretraining of Mistral 7B on all English PubMed Central abstracts and articles.
- Multilingual variants: additional models adapted to PubMed Central excerpts in eight other languages, enabling medical NLP beyond English.
- Quantization: quantized versions for lightweight, local deployment on commodity hardware.
- Instruction-tuned model: created by fine-tuning BioMistral on Alpaca biomedical synthetic instruction data.
- Open release: all models, training data, code, and evaluation pipelines are public.
- BioMistral outperforms other open-source 7B-scale medical models.
- It approaches the performance of larger closed-source medical LLMs on several tasks.
- Chain-of-thought (CoT) reasoning remains difficult for small medical LLMs: prompt-level CoT strategies did not consistently improve results and can even hurt performance.
- 7B scale limits complex reasoning abilities.
- English-centric continued pretraining for the base model; multilingual quality varies by language.
- Better to Ask in English: Cross-Lingual Evaluation of Large Language Models
- Original paper: BioMistral: A Collection of Open-Source Pretrained Large Language Models for Medical Domains. arXiv:2402.10373
Evaluation
BioMistral was evaluated on 10 established medical benchmarks. Key findings:
Why it matters
Fully open medical LLMs support privacy-preserving, locally deployable clinical applications and transparent, reproducible research — addressing the licensing and data-governance limits of closed models in healthcare.